VGF: a biomarker and potential target for the treatment of neuropathic pain?

Neuropathic pain (NP) remains an area of considerable unmet medical need. A persistent challenge in the management of NP is to target the specific mechanisms leading to a change from normal to abnormal sensory perception while ensuring that the defensive pain perception remains intact. Targeting VGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Nadia, Okuse, Kenji, Rice, Andrew S.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Neuropathic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882576/
https://www.ncbi.nlm.nih.gov/pubmed/31875189
http://dx.doi.org/10.1097/PR9.0000000000000786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882576/
https://www.ncbi.nlm.nih.gov/pubmed/31875189
http://dx.doi.org/10.1097/PR9.0000000000000786

Ejemplares similares